Patent · US Active

Physiology and pathophysiology of human gut: intestine-on-chip

US11566231B2 · kind B2 · utility

0Cited by
0References
44Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2020
Grant dateJan 31, 2023
Priority date
Expiry dateJul 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/25
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflamm…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.